Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3).
| Autor: | Byoung-Gie Kim1 bgkim@skku.edu, Chel Hun Choi1, Ngoi, Natalie2, Tan, David2, Jae-Weon Kim3 |
|---|---|
| Zdroj: | Journal of Gynecologic Oncology. 2024 Supplement, Vol. 35, p31-32. 2p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|